A A A

Boehringer Ingelheim

Boehringer Ingelheim

Through Boehringer Ingelheim’s participation in medical and pharmaceutical research, both in Canada and worldwide, they have contributed to significant improvements in healthcare and developed innovative and cost effective medicines. Boehringer Ingelheim has earned a reputation as a leader in the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD), and have broadened the scope of their work to include diseases such as hypertension, stroke, arthritis, benign prostatic hyperplasia (BPH), Parkinson’s disease and HIV/AIDS.